Russia
This week’s big story: Stop banning exports of medical products, report says
March 10 by Leila HawkinsPharma Logistics IQ dives into a new report calling for international cooperation and an end to banning medical exports.
This week’s big story: War in Europe and pharma supply chains
March 02 by Leila HawkinsPharma Logistics IQ looks at the potential impact of the Russia-Ukraine war on supply chains, with India likely to be the first country affected
Global Cold Chain Report
March 30 by Pharma Logistics EditorThis mega report presents an in-depth look at the opportunities and challenges in China, the EU, India, Latin America and Russia. Inside you will find articles, videos, stats and useful resources, wit...
GDP Implementation in Russia, Belarus and Kazakhstan
March 18 by Mikhail KhazanchukFor long years pharmaceutical industry in Russia has been awaiting implementation of GxP-practices as a legally binding requirement. Start was given at the end of 2013 when GMP was officially put in f...
Distribution Practices in Russia
February 25 by Pharma Logistics EditorMikhail Khazanchuk, Quality and Compliance Manager, Russia and CIS, Johnson & Johnson, shares his insights on distribution practices in Russia & tips for overcoming related challenges.
Temperature Controlled Storage & Distribution in Emerging Markets
October 01 by Pharma Logistics Editor5 Local Insights from the Frontline The emerging markets continue to be an attractive proposition for pharmaceutical and biotech manufacturers. However, in many emerging countries there are unique ch...
Novo Nordisk's Quality Control Manager Mikhail Khazanchuk on GDP and Cold Chain Distribution in Russia
January 16 by Mikhail HazanchukAhead of Cool Chain Russia & CIS 2014, taking place 23 - 25 April, 2014 in Moscow, Russia, Mikhail Khazanchuk, Quality Control Manager at Novo Nordisk, spoke to Cold Chain IQ about the broken cool...
Successful Cold Chain Logistics from Europe to Russia
February 03 by Cold Chain IQCold Chain logistics and distribution is one of the most significant and complex challenges for the biopharmaceutical industry, owing to the importance of keeping products such as vaccines, serums and...
Customs Clearance is the Biggest Challenge for Pharma Cool Chain in Russia & CIS
September 30 by Cold Chain IQAccording to Frost and Sullivan the Russian pharma market expected to be worth $37.15bn in 2016. As the region prepares for a significant growth phase, the article "Russia: Needs to Invest in Cold Cha...
Customs Clearance and Border Crossing Named the Biggest Challenge in Temperature Controlled Shipments to Russia
October 26 by Pharma IQRussia's pharmaceutical industry is poised for growth. Driven by increased state investment and expansion in the parapharmaceuticals sector, the country's market is set for a compound annual growth ra...